Abbott Takes on Pain with St. Jude Acquistion

Abbott Takes on Pain with St. Jude Acquistion

Abbott’s acquisition of St. Paul, MN-based device company St. Jude Medical will impact a number of medical device markets, and place the pharmaceutical and testing giant into a leading position in the medical device industry, Non-medical pain relief is an increasing focus point with attention on the dangers of pain medication and the need to find alternatives to reduce chronic pain,” said Bruce Carlson, Publisher of Kalorama Information. “Abbott builds on its cardiovascular device properties with this deal, and that is a big focus of press coverage. St. Jude’s impressive spinal cord offering should not be obscured in this transaction. according to Kalorama Information. The healthcare market research firm finds that the purchase puts Abbott into the electrostimulation market particularly in neurostimulation, a fast-growing market where St. Jude is one of three top companies.


CRM Devices Market Reaches 13 Billion

CRM Devices Market Reaches 13 Billion

The global market for cardiac rhythm management devices such as pacemakers and defibrillators is worth about $13 billion for 2015, according to our recent report Cardiac Rhythm Device Markets ( http://www.kaloramainformation.com/Cardiac-Rhythm-Management-8911435/.) The market has benefited from the demand to move to a more mobile, wireless and efficient system both within major health facilities and in the home treatment markets. There is also an increasing trend to upgrade to more portable devi...